Highlights
MAML1, a core Notch transcriptional coactivator, is implicated as a candidate gene in congenital heart disease, particularly ventricular septal defect.
A patient-derived MAML1 Q401K variant reproduced septal and valvular phenotypes in knock-in mice and CRISPR-edited human heart organoids.
